 Home > Medical News > Latest Medical News > mTOR-targeted inhibitors receive FDA priority review qualifications

mTOR-targeted inhibitors receive FDA priority review qualifications

 Last Update: 2021-08-15
 Source: Internet
 Author: User

Tags

fish scale drug

nodular acne treatment

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On July 26, 2021, Aadi Bioscience announced that the U.

Fyarro has previously been granted Orphan Drug Designation, Fast Track Designation and Breakthrough Therapy Designation by the FDA

PEComa is an ultra-rare subtype of soft tissue sarcoma driven by mTOR activation.

mTOR is a type of serine/threonine kinase.

▲Fyarro is an anti-cancer therapy targeting the mTOR pathway (picture source: Aadi Bioscience's official website)

Fyarro is a nanoparticle albumin inhibitor injection suspension that targets the mTOR pathway

The submission of this new drug application is based on the positive data obtained from the drug in the AMPECT registration trial

▲Efficacy data of the AMPECT registered trial (picture source: Aadi Bioscience's official website)

Note: The original text has been deleted

Reference materials:

[1] Aadi Bioscience Announces FDA Acceptance and Priority Review for the New Drug Application of Fyarro™ for the Treatment of Advanced Malignant PEComa.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.